Accelerate Diagnostics, Inc.

NASDAQ:AXDX

1.87 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Revenue 12.05912.75211.78211.1659.2975.674.1770.2460.1470.1220.0480.2361.1212.2461.270.4760.1830.2130.5020.1190.8510.6540.8561.5672.8987.3812.52.1
Cost of Revenue 9.5099.44912.1636.7064.8973.1871.002000000000.010.0570.0420.1560.0660.1490.1840.5350.6441.2291.1540.30.3
Gross Profit 2.553.303-0.3814.4594.42.4833.1750.2460.1470.1220.0480.2361.1212.2461.270.4660.1260.1710.3470.0530.7020.470.3210.9231.6696.2282.21.8
Gross Profit Ratio 0.2110.259-0.0320.3990.4730.4380.76111111110.980.6910.8040.690.4470.8250.7180.3750.5890.5760.8440.880.857
Reseach & Development Expenses 25.35326.91521.94321.25525.34527.63822.328.19626.02220.05310.6730.4320.4550.5020.7460.8810.9922.1561.3050.5540.5690.3270.123000.0690.10
General & Administrative Expenses 00000000004.3122.9450.810.8690.9200000000.7091.5270.9980.95700
Selling & Marketing Expenses 000000000000.0080.010.0010.01300000000.2890.8171.1981.29100
SG&A 31.22539.19349.23646.90451.88655.21445.05736.217.88210.6954.3122.9540.820.8710.9331.0180.9360.9040.9950.9781.190.7420.9982.3452.1962.2481.10.5
Other Expenses 13.063-0.227-0.02-0.06-0.014-0.028-0.1842.3511.7920.888-0.0040.2050.2560.2610.270.2940.3140.3160.3060.2930.490.170.6380.896000.20.1
Operating Expenses 56.57866.10871.17968.15977.23182.85267.35766.74745.69631.63615.3483.5911.5311.6341.9492.1932.2413.3762.6061.8262.2491.2391.763.242.1962.3171.40.6
Operating Income -54.028-62.805-71.56-63.7-72.831-80.369-64.182-66.501-45.549-31.517-15.311-5.352-0.4090.612-0.679-1.728-2.114-3.205-2.259-1.773-1.547-0.769-1.439-2.317-0.5273.9110.81.2
Operating Income Ratio -4.48-4.925-6.074-5.705-7.834-14.174-15.366-270.329-309.857-258.336-317.093-22.678-0.3650.272-0.535-3.633-11.546-15.066-4.499-14.947-1.818-1.176-1.681-1.478-0.1820.530.320.571
Total Other Income Expenses Net -6.740.235-6.097-14.503-11.585-0.478-0.259-0.0770.051-0.003-0.016-1.9730.0150.024-0.053-0.0160.079-0.0070.015-0-0.148-0.142-0.9730.2790.5660.5370.3-1.2
Income Before Tax -60.768-62.57-77.657-78.203-84.416-88.115-63.533-66.107-45.498-31.46-15.282-5.311-0.3790.642-0.714-1.68-1.924-3.031-2.091-1.699-1.395-0.719-1.865-1.4560.0394.4481.21.1
Income Before Tax Ratio -5.039-4.907-6.591-7.004-9.08-15.541-15.21-268.728-309.51-257.869-316.492-22.504-0.3380.286-0.562-3.534-10.508-14.248-4.164-14.322-1.64-1.099-2.179-0.9290.0130.6030.480.524
Income Tax Expense 0.85-0.0770.0450.005-0.1110.211-0.6510.2670.074-0.527-0.0221.9560.379-0.6420.714-0.047-0.19-0.174-0.168-0.789-0.019-0.318-0.318-0.5330.0311.570.2-1.1
Net Income -61.618-62.493-77.702-78.208-84.305-88.326-62.882-66.374-45.498-30.933-15.282-5.311-0.3790.642-0.714-1.68-1.924-3.031-2.091-0.909-1.376-0.401-1.547-0.9230.072.87811.1
Net Income Ratio -5.11-4.901-6.595-7.005-9.068-15.578-15.054-269.813-309.51-253.549-316.492-22.504-0.3380.286-0.562-3.534-10.508-14.248-4.164-7.667-1.618-0.613-1.808-0.5890.0240.390.40.524
EPS -4.94-7.61-12.59-13.96-15.47-16.21-11.63-12.94-10.11-7.09-4.06-4.26-0.350.6-0.7-1.67-1.93-3.04-2.1-0.91-1.45-0.48-2.02-1.190.13.81.58.8
EPS Diluted -4.94-7.61-12.59-13.96-15.47-16.21-11.63-12.94-10.11-7.09-4.06-4.26-0.350.6-0.7-1.67-1.93-3.04-2.1-0.91-1.45-0.48-2.01-1.190.13.51.26.8
EBITDA -50.774-59.481-68.974-59.908-67.434-74.991-64.107-63.656-43.683-30.562-14.926-1.177-0.1680.849-0.356-1.418-1.879-2.881-1.968-1.49-1.105-0.4570.172-1.70.1764.2390.71.3
EBITDA Ratio -4.21-4.664-5.854-5.366-7.253-13.226-15.348-258.764-297.163-250.508-309.116-4.987-0.150.378-0.28-2.981-10.263-13.546-3.92-12.559-1.299-0.6990.201-1.0850.0610.5740.280.619